GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Aclarion
Aclarion has developed a technology for diagnosing back pain. Its stock price is a bet that its method will become a new standard in this complex field of medicine. The chart reflects investor expectations for commercialization.
Share prices of companies in the market segment - Diagnostic medical equipment
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific intervertebral disc causing the pain. We've categorized it as "Diagnostic Medical Equipment." The chart below shows how the market is evaluating innovations in spinal surgery.
Broad Market Index - GURU.Markets
Aclarion is a medical company that has developed a technology for diagnosing low back pain by analyzing signals from intervertebral discs. It is a component of the GURU.Markets index. The chart below represents the market. See how its stock compares to the diagnostics sector.
Change in the price of a company, segment, and market as a whole per day
ACON - Daily change in the company's share price Aclarion
Aclarion, Inc.'s daily price change reflects volatility in the medical diagnostics sector. The indicator demonstrates sensitivity to the introduction of its MRI spectroscopy technology for back pain diagnostics.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the source of the pain. This represents an innovative new field in medical diagnostics. The chart below shows volatility in the medical device sector, helping assess how the market is responding to ACON's technology.
Daily change in the price of a broad market stock, index - GURU.Markets
Aclarion has developed a technology for diagnosing back pain using MRI analysis. Shares of this innovative medtech company are responding to clinical advances and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Aclarion
Aclarion, Inc.'s year-over-year performance is a story about the commercialization of its Nociscan diagnostic platform. Its 12-month market cap growth reflects its success in convincing surgeons and insurance companies that its MRI analysis can accurately determine whether a disc is the source of pain, thereby avoiding unnecessary surgeries.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Aclarion, a company developing technology to diagnose back pain, is betting on medical innovation. Its performance relative to the sector will reveal how much investors believe in its ability to commercialize its unique technology and secure regulatory approval.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aclarion, with its back pain diagnostic technology, is attempting to solve a complex medical problem. Its performance relative to the market is a testament to whether the medical community will embrace its innovative approach. Success will mean a revolution in diagnostics and explosive growth that outpaces the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Aclarion
Aclarion is a medical company developing technology for back pain diagnostics. Its monthly performance reflects progress in the commercialization of its Nociscan platform. News about its clinical implementation and research data are key.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
The medical diagnostics market is constantly seeking more accurate diagnostic methods. The dynamics of this sector, shown in the graph, reflect the demand for innovation. In this area, companies like Aclarion offer their technologies to solve complex medical problems.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aclarion, a maker of diagnostic software for spine surgery, is betting on innovation in medical technology. The company's shares are driven by news of its technology being implemented in hospitals rather than by general market trends, creating an independent profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Aclarion
Aclarion has developed a technology for accurately diagnosing the source of back pain, a major medical problem. Its weekly stock price reflects news of its method's implementation in clinics, data confirming its accuracy, and insurance company coverage decisions.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Aclarion has developed MRI technology that helps determine whether a specific intervertebral disc is the source of chronic back pain. This is an important diagnostic clarification. The chart below shows how investors view the potential of this technology and how its performance compares to the medical device sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Aclarion has developed MRI technology. This is an important diagnostic advance. The chart will show how investors view the potential of this technology and how its performance compares to the broader market, driven by other factors.
Market capitalization of the company, segment and market as a whole
ACON - Market capitalization of the company Aclarion
Grainka on capitalization on Aclarion e tax on investitorite for non-diagnosis technology. Graphikot ja drazuva verbat na pasarot v nejziniot software koji pomaga da se identifikava izrovo na bolka v dolniot delo na grbot. The low risk of harm shows a huge potential, but there is also a high risk of commercialization of new medical technologies.
ACON - Share of the company's market capitalization Aclarion within the market segment - Diagnostic medical equipment
Aclarion has developed technology for non-invasive back pain diagnosis. Its market share in the medical device sector is small, but it addresses a very common problem. The company is betting on its software platform, which analyzes MRI images to pinpoint the source of pain.
Market capitalization of the market segment - Diagnostic medical equipment
Below is a graph showing the total value of the entire diagnostic equipment market. For Aclarion, with its MRI spectroscopy technology for back pain diagnosis, this line represents a map of the future. The rising graph reflects how technology is making diagnostics more accurate and personalized, which is the core of the company's business.
Market capitalization of all companies included in a broad market index - GURU.Markets
Aclarion has developed a technology for diagnosing back pain using MRI signals to pinpoint the specific disc causing the pain. Its market capitalization is the "pain detector" rating. This represents the market share of accurate diagnostics for one of the most common complaints.
Book value capitalization of the company, segment and market as a whole
ACON - Book value capitalization of the company Aclarion
Aclarion developed a technology for diagnosing back pain using MRI analysis. Its book value is derived from its intellectual property (software patents) and the financial resources for commercialization. How has this diagnostic capital evolved? The chart below shows this history.
ACON - Share of the company's book capitalization Aclarion within the market segment - Diagnostic medical equipment
Aclarion, Inc. has developed technology for back pain diagnostics. Its software platform requires IT infrastructure to analyze MRI images, and its business requires back-office operations. The chart shows its share of tangible assets at the intersection of software and medical diagnostics.
Market segment balance sheet capitalization - Diagnostic medical equipment
Aclarion is a medical diagnostics company. Compared to the capital-intensive healthcare sector, its model is knowledge-intensive. The industry's asset chart reflects the value of hospitals. Aclarion, on the other hand, invests in AI and software for MRI analysis.
Book value of all companies included in the broad market index - GURU.Markets
Aclarion's assets are not MRI machines, but AI-powered software that analyzes MRI images to accurately determine the source of chronic back pain. Its book value reflects its technology platform, which helps surgeons make more informed decisions.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Aclarion
Aclarion is a medical technology company that uses MRI spectroscopy to diagnose back pain. Its market value is derived from its unique technology and its potential to help surgeons make more informed decisions.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Aclarion has developed a technology for diagnosing back pain. It represents a huge market. The chart shows how investors view its innovative approach and its potential to become a new standard in diagnostics, potentially significantly improving treatment outcomes.
Market to book capitalization ratio for the market as a whole
Aclarion has developed a technology for diagnosing back pain using MRI analysis. This is an innovative approach to medical diagnostics. The company's market value reflects the potential of its technology to become a new standard. This chart shows how investors value breakthrough solutions that improve diagnostic accuracy.
Debts of the company, segment and market as a whole
ACON - Company debts Aclarion
Aclarion is developing a technology for diagnosing back pain. As a medical device company in the commercialization stage, it is raising capital to fund sales and marketing, as well as to conduct research to prove its effectiveness. This chart shows the financial costs of implementing the new diagnostic method.
Market segment debts - Diagnostic medical equipment
Aclarion has developed a technology for non-invasive low back pain diagnostics, using MRI signals to pinpoint the specific disc causing the pain. This graph illustrates how the medical technology company is funding clinical research and commercialization of its innovative diagnostic tool in an effort to transform the treatment of chronic pain.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Aclarion
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific intervertebral disc causing the pain. Commercializing such an innovative diagnostic tool requires clinical research and marketing. This chart shows how the company is using debt to bring its technology to market.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Aclarion has developed a technology for diagnosing low back pain, helping surgeons pinpoint the source. It's an important, yet niche, area. This chart shows how the company is funding the commercialization of its technology. It compares its debt load to the market capitalization of the entire medical device industry.
Debt to book value of all companies in the market
Aclarion has developed a technology for diagnosing low back pain by analyzing MRI images. Bringing this new diagnostic method to market requires investment in clinical trials and approvals. How dependent is the company on debt? This chart of total market debt helps evaluate its financial strategy as it moves toward commercialization.
P/E of the company, segment and market as a whole
P/E - Aclarion
Aclarion has developed technology for non-invasively diagnosing low back pain by analyzing MRI images. This chart shows how investors value its software-as-a-service (SaaS) for the medical market. The valuation depends on the adoption of its technology by surgeons and insurance companies.
P/E of the market segment - Diagnostic medical equipment
Aclarion, Inc. has developed magnetic resonance spectroscopy technology for non-invasive diagnosis of low back pain, helping surgeons pinpoint the specific disc causing the pain. This graph illustrates the average rating in the diagnostic medical equipment sector, which values technologies that improve diagnostic accuracy and treatment outcomes.
P/E of the market as a whole
Aclarion, Inc. has developed a technology for non-invasive low back pain diagnostics using MRI spectroscopy to determine whether an intervertebral disc is the source of the pain. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether ACON's rating reflects confidence in its unique diagnostic technology or general trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Aclarion
Aclarion has developed a technology for non-invasively diagnosing the source of chronic low back pain using MRI signals. This could help surgeons more accurately identify surgical targets. This chart reflects the investors' belief that this technology will become a new standard in pain diagnostics and will be widely adopted by the medical community.
%20P%2FE%20Aclarion&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Aclarion&v=1772597669740 "Chart of the company's future (projected) P/E Aclarion")
Future (projected) P/E of the market segment - Diagnostic medical equipment
Aclarion has developed a technology for non-invasive diagnosis of low back pain, helping surgeons pinpoint the specific intervertebral disc causing the pain. The chart shows future revenue forecasts for the sector, helping to understand the market's confidence in this diagnostic technology becoming the standard in spinal surgery.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Diagnostic-medical-equipment&v=1772597669772 "Future (projected) P/E graph of the market segment - Diagnostic medical equipment")
Future (projected) P/E of the market as a whole
Aclarion has developed technology for analyzing MRI images that helps determine whether a specific intervertebral disc is the source of back pain. It's a diagnostic tool. This healthcare market sentiment chart helps understand how investors view the prospects of innovative diagnostic technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772597669823 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Aclarion
Aclarion has developed an MRI-based technology to pinpoint the specific spinal disc causing chronic back pain. Profits depend on the adoption of this diagnostic technique. This chart shows the financial trajectory of the company, whose innovation could help surgeons make more accurate decisions.
Profit of companies in the market segment - Diagnostic medical equipment
Aclarion, Inc. has developed a technology for non-invasive diagnosis of low back pain using MRI spectroscopy to determine whether an intervertebral disc is the source of the pain. This graph illustrates the overall profitability of the diagnostic medical equipment sector, where innovative methods that help make more accurate diagnoses and avoid unnecessary surgeries are in high demand.
Overall market profit
Aclarion has developed a technology for diagnosing low back pain. The company operates at the intersection of medical diagnostics and IT. Demand for its technology is driven by its clinical value and acceptance by the medical community. This process is independent of general economic cycles, as can be seen in this graph, as chronic pain always requires treatment.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Aclarion
Aclarion has developed technology for non-invasive diagnosis of the source of low back pain, helping surgeons make surgical decisions. Future revenue depends on the adoption of this diagnostic platform by the medical community. This chart reflects analyst expectations regarding its potential to improve back pain treatment outcomes.
%20profit%20of%20the%20company%20Aclarion&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Aclarion&v=1772597670038 "Graph of future (projected) profit of the company Aclarion")
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Aclarion has developed technology for non-invasive diagnosis of low back pain. Its system uses MRI signals to determine whether an intervertebral disc is the source of pain, helping surgeons make decisions. This graph shows revenue expectations for the diagnostic medical equipment sector, helping to assess the potential of Aclarion's technology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Diagnostic-medical-equipment&v=1772597670066 "Graph of future (predicted) profits of companies in a market segment - Diagnostic medical equipment")
Future (predicted) profit of the market as a whole
Aclarion is a medical technology company that has developed software for back pain diagnostics. The company's success depends on the adoption of its technology by surgeons and hospitals. This economic outlook impacts healthcare system budgets and their willingness to implement innovative diagnostic tools.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772597670084 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Aclarion
Aclarion has developed a technology for diagnosing low back pain by analyzing MRI images. Revenue growth will depend on the adoption of this technology by surgeons. This chart shows how investors assess its potential to solve one of the most common and complex medical problems.
P/S market segment - Diagnostic medical equipment
Aclarion has developed technology for non-invasive diagnosis of low back pain. Their software analyzes MRI images to determine which discs are the source of pain, helping surgeons make more accurate decisions. This chart shows the average revenue estimate for the sector, helping to assess how the market views this innovative diagnostic technology.
P/S of the market as a whole
Aclarion has developed technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific intervertebral disc causing the pain. This chart highlights how the value of such diagnostic companies depends on their ability to solve complex medical problems and improve treatment outcomes.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Aclarion
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific discs causing the pain. Estimating future revenue is important for such a diagnostic company. It reflects investors' perception of its technology's potential to become a standard in spinal surgery, improving surgical outcomes and reducing costs.
%20P%2FS%20Aclarion&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Aclarion&v=1772597670354 "The graph of the company's future (projected) P/S Aclarion")
Future (projected) P/S of the market segment - Diagnostic medical equipment
Aclarion has developed a technology based on MRI spectroscopy that helps determine whether an intervertebral disc is the source of chronic back pain. This chart compares the company's estimated future sales with expectations for the medical diagnostics sector. It shows whether investors believe its technology will become an important tool for surgeons in their decision-making.
%20P%2FS%20market%20segment%20graph%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Diagnostic-medical-equipment&v=1772597670403 "Future (projected) P/S market segment graph - Diagnostic medical equipment")
Future (projected) P/S of the market as a whole
Aclarion has developed a technology for non-invasive low back pain diagnostics that helps surgeons pinpoint the specific intervertebral disc causing the pain. The company's success depends on the medical community's acceptance of this technology. This graph of investor expectations reflects their belief that accurate diagnostics can improve treatment outcomes.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772597670483 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Aclarion
The graph shows Aclarion, Inc.'s revenue from its software platform, which uses MRI scans to identify the source of chronic low back pain. Revenue growth will depend on the adoption of this technology in clinical practice as a tool for more accurate diagnosis.
Sales of companies in the market segment - Diagnostic medical equipment
Aclarion has developed technology for more accurate diagnosis of the causes of low back pain. As it commercializes, its revenue structure will reflect a split between software sales to hospitals and fees for each analysis performed. This reflects its SaaS approach to medical diagnostics.
Overall market sales
Aclarion, Inc. has developed a technology for non-invasive diagnosis of low back pain, helping surgeons pinpoint the specific disc causing the pain. This general economics statement doesn't address the fundamental need for more accurate diagnostics, which can improve surgical outcomes and spare patients unnecessary procedures.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Aclarion
Aclarion has developed a technology for non-invasive low back pain diagnostics using magnetic resonance spectroscopy to pinpoint the specific intervertebral disc causing the pain. Future revenue is dependent on the implementation of this technology. The chart reflects analysts' expectations for demand for its innovative diagnostic platform.
%20sales%20of%20the%20company%20Aclarion&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Aclarion&v=1772597670748 "Schedule of future (projected) sales of the company Aclarion")
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Aclarion has developed technology for analyzing MRI images to determine the source of low back pain. This graph illustrates the forecast for the diagnostic equipment market. Is there growing demand for AI solutions that help doctors make more accurate diagnoses? This determines the overall outlook for the industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Diagnostic-medical-equipment&v=1772597670884 "Schedule of future (projected) sales of companies in the market segment - Diagnostic medical equipment")
Future (projected) sales of the market as a whole
Aclarion has developed a technology for diagnosing low back pain. Demand for its diagnostic services is determined by their clinical value, physician acceptance, and insurance coverage. This graph of overall economic activity is minimal, as the need for accurate diagnosis of chronic pain is a pressing medical issue in any economic environment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772597671014 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Aclarion
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific intervertebral disc causing the pain. This graph shows the company's path to commercialization. Profitability depends on surgeon acceptance of its technology, insurance reimbursement, and proof that it improves surgical outcomes.
Market segment marginality - Diagnostic medical equipment
Aclarion, Inc. has developed software that uses MRI images to determine whether a specific intervertebral disc is the source of chronic low back pain. This graph depicts the company's financial status during the commercialization stage, where profitability depends on surgeon adoption of its technology and reimbursement from insurance companies.
Market marginality as a whole
Aclarion has developed a technology to more accurately diagnose the causes of low back pain. Its success depends on the acceptance of this technology by surgeons and insurance companies. This overall profitability chart reflects the state of the healthcare system and its willingness to implement innovative diagnostic tools to reduce the number of unnecessary surgeries.
Employees in the company, segment and market as a whole
Number of employees in the company Aclarion
Aclarion has developed a technology for non-invasive low back pain diagnostics, helping surgeons pinpoint the specific discs causing the pain. Its small team is focused on commercializing this technology. This chart shows how the company is building its commercial team to promote its diagnostic platform to physicians.
Share of the company's employees Aclarion within the market segment - Diagnostic medical equipment
Aclarion has developed MRI technology that helps determine whether a herniated disc is the source of pain. Commercializing this diagnostic software requires a team of image processing and sales specialists. This chart shows the company's market share, reflecting its efforts to introduce this new technology into medical practice.
Number of employees in the market segment - Diagnostic medical equipment
Aclarion has developed technology for non-invasive diagnosis of low back pain. Its software analyzes MRI images to determine which discs are the source of pain. The graph illustrates employment in the diagnostic medical equipment sector. This technology can help surgeons make more informed decisions.
Number of employees in the market as a whole
Aclarion has developed a technology for non-invasive back pain diagnostics, helping to determine whether an intervertebral disc is the source of the pain. Its growth depends on the adoption of this innovation in medical practice. This chart shows the big picture, and Aclarion is an example of how MedTech companies are creating solutions to complex medical problems and creating new jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Aclarion (ACON)
Aclarion (ACON) is a medical technology company that developed Nociscan software, which uses MRI spectroscopy to determine whether an intervertebral disc is the source of pain. Their value lies in their algorithm. This chart shows the market value per employee, which is a direct valuation of their unique diagnostic IP (software).
%20of%20the%20company%20Aclarion%20(ACON)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Aclarion-ACON&v=1772597671702 "Chart of market capitalization per employee (in thousands of dollars) of the company Aclarion (ACON)")
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Aclarion (ACON) has developed a technology for non-invasive low back pain diagnostics, helping surgeons determine whether an intervertebral disc is the source of the pain. In the field of medical diagnostics, this parameter reflects the clinical value of their method. The high capitalization per employee suggests that their technology has the potential to significantly improve the outcomes of spinal surgeries.
%20by%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Diagnostic-medical-equipment&v=1772597671757 "Market capitalization per employee (in thousands of dollars) by market segment - Diagnostic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Aclarion has developed MRI analysis software that helps identify the source of chronic back pain. In the digital healthcare sector, the value lies in the algorithm. The graph shows a high rating for the employee, as its technology can dramatically improve diagnostics and spare patients unnecessary surgeries.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772597671846 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Aclarion (ACON)
Aclarion is a company that has developed technology (MRI-based software) for identifying the source of chronic back pain. It is a diagnostic MedTech. This graph shows the stage of commercialization of this software. The loss per employee represents the R&D and marketing phase to convince doctors of the technology's effectiveness.
%20Chart%20Aclarion%20(ACON)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Aclarion-ACON&v=1772597671991 "Company Profit Per Employee (in thousands of dollars) Chart Aclarion (ACON)")
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Aclarion, Inc. is a medical technology company that has developed software for diagnosing low back pain. In digital healthcare, efficiency per employee reflects the value of their algorithms. This graph shows the financial return generated by the team that created a tool capable of improving treatment outcomes and reducing healthcare costs.
%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Diagnostic-medical-equipment&v=1772597672097 "Chart of profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Aclarion is a medical technology company. They developed MRI-based software (Nociscan) that helps doctors determine whether a herniated disc is the source of chronic back pain. It's a B2B SaaS solution for surgeons. This chart shows how niche medical software, where value is created by algorithms, compares in terms of staff efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772597672187 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Aclarion (ACON)
Aclarion has developed technology for more accurate diagnosis of back pain causes. This graph demonstrates the commercial success of their innovative diagnostic software. Increased revenue per employee will indicate that their technology is being adopted by clinics and helps doctors make more informed treatment decisions.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Aclarion-ACON&v=1772597672285 "Sales chart per company employee Aclarion (ACON)")
Sales per employee in the market segment - Diagnostic medical equipment
Aclarion (ACON) is a medtech company that has developed software (NOCISCAN) that uses MRI scans to determine whether low back pain is discogenic (caused by a disc). It's a SaaS diagnostic service. This chart shows the average revenue in the sector. For ACON, this is an indicator of how productive their R&D and sales teams are in promoting this software to surgeons.
Sales per employee for the market as a whole
Aclarion (ACON) is not a hardware manufacturer, but a software developer. Their SaaS platform, NOCISCORE, analyzes MRI scans to help surgeons determine whether a disc is the source of pain. This indicator demonstrates the scalability of their AI model.
Short shares by company, segment and market as a whole
Shares shorted by company Aclarion (ACON)
Aclarion (ACON) has developed MRI spectroscopy technology that it claims helps pinpoint the source of back pain. This chart tracks short positions. Sellers may doubt that this technology will be adopted by doctors and insurance companies, or that it is truly more accurate than existing methods.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Aclarion-ACON&v=1772597672515 "Short Shares Chart for the Company Aclarion (ACON)")
Shares shorted by market segment - Diagnostic medical equipment
Aclarion (ACON) developed the Nociscan diagnostic platform (based on MRI spectroscopy) to determine whether intervertebral discs are the source of back pain. This chart shows the total short position in the diagnostics sector. It reflects investor skepticism regarding the slow adoption of new diagnostic methods.
Shares shorted by the overall market
Aclarion develops software for back pain diagnostics (MRI analysis). This chart reflects the overall market pessimism. Investors fear that during the crisis, hospitals and insurers will avoid spending money on "innovative" diagnostic software, preferring older methods. This R&D project is vulnerable to cuts in healthcare IT budgets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Aclarion (ACON)
Aclarion uses AI to analyze MRIs to determine whether back pain is discogenic. It's a SaaS solution for surgeons. This indicator measures the "temperature" of trust in their AI. It "warms up" based on news about published studies confirming their accuracy or partnerships with clinics.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Aclarion-ACON&v=1772597673078 "RSI 14 indicator chart for the company's stock Aclarion (ACON)")
RSI 14 Market Segment - Diagnostic medical equipment
Aclarion (ACON) is a medical "pain map." They use AI to analyze MRI images to pinpoint the exact disc in the spine that's causing chronic pain. This chart tracks the pulse of the Diagnostic Equipment sector, helping to differentiate ACON's technology from the overall "overheated" or "oversold" medtech industry.
RSI 14 for the overall market
For Aclarion (ACON), an R&D company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the cash spigot is turned off, and cash-burning companies risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ACON (Aclarion)
Aclarion is a medical technology company that developed Nociscan, a SaaS MRI software that helps surgeons determine whether a specific disc is the source of back pain. This chart shows the speculative average 12-month price target from analysts, based on their belief in the adoption of this diagnostic.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ACON-Aclarion&v=1772597673299 "A chart showing analyst consensus forecasts for the expected stock price. ACON (Aclarion)")
The difference between the consensus estimate and the actual stock price ACON (Aclarion)
Aclarion is a "pain diagnostic." Their AI platform (Nociscan) analyzes MRI scans to *for the first time* objectively determine whether a disc is the source of back pain. This chart shows the analysts' forecast for the stock's upside or downside. It measures the gap between the price and the forecast, reflecting their confidence in the implementation of this "smart" diagnostic.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ACON-Aclarion&v=1772597673376 "A chart showing the difference between the consensus forecast and the actual stock price. ACON (Aclarion)")
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Aclarion is a "pain detector." The company has developed an AI platform (Nociscan) that analyzes MRI scans to pinpoint the exact disc in the spine that is causing pain. This graph reflects the general expectations of analysts across the diagnostic equipment sector. It shows whether experts believe in "AI-based pain diagnostics."
Analysts' consensus forecast for the overall market share price
Aclarion is a medical company that developed software (Nociscan) that uses AI to analyze MRIs to determine whether a disc is the source of chronic back pain. This chart shows overall market sentiment. For ACON, whose business is implementing new diagnostic technology, overall optimism (the rising chart) is important for funding and convincing insurers.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Aclarion
Aclarion is a back pain map. Their signature feature is their AI-powered SaaS software (Nociscan), which analyzes a patient's MRI and (they claim) identifies the specific disc causing the pain. This graph is a summary of their implementation history, reflecting their (very slow) journey to receiving reimbursement from insurance companies and convincing surgeons.
AKIMA Market Segment Index - Diagnostic medical equipment
Aclarion has revolutionized back pain diagnostics. Their NOCISCAN technology analyzes MRIs to determine whether pain is actually originating from a specific spinal disc. This helps surgeons. This graph compares their composite index with the sector, showing how this unique diagnostic technology outperforms the competition.
The AKIM Index for the overall market
Aclarion is a medtech company that uses spectroscopy (Nociscan) to diagnose the source of low back pain. It helps avoid unnecessary surgeries. This chart, which reflects the market average, is a backdrop. It helps assess how ACON, a diagnostic tool for spinal surgery, compares to overall macroeconomic trends.
